Abstract:Objce tive To investigate the effect and significance of down-regulation of Oct4 gene on biological characteristics of MDA-MB-231 breast cancer stem cells.Methods Breast cancer cell line MDA-MB-231 cells were used in this study.Breast cancer stem cells were isolated and enriched by serum-free culture.The obtained stem cells were identified through calculating the percentages of CD44 and CD24 stem cells by FACS and evaluating the paclitaxel resistance in vitro and tumorigenicity in mice.RT-PCR, real-time PCR (qPCR) and Western blot were used to detect Oct4 expression.RNA interference was applied to induce Oct4 down-regulation.The interference experiment set up a control group ( no siRNA transfection) , negative control group ( negative siRNA group,transfection of siRNA sequences without any interfering effect on the cells) and Oct4 siRNA group ( transfection of siRNA with interfering effect on the Oct4 gene) .Methyl thiazolyl tetrazolium ( MTT ) and Transwell chamber tests were conducted to detect the proliferation and invasion ability of MDA-MB-231 breast cancer stem cells after Oct4 knock-down, and paclitaxel inhibition test was applied to evaluate drug resistance of MDA-MB-231 breast cancer stem cells after Oct4 knock-down. Resulst MDA-MB-231 breast cancer stem cells grew as spheres cultured in serum-free suspension.MDA-MB-231 breast cancer stem cells showed a higher percentage of CD44+C/D24 -/low cells (97.2%) than that in MDA-MB-231 breast cancer cells ( 76.6%) ( P<0.05) .The tumor size in mice inoculated with MDA-MB-231 breast cancer stem cells was (124.60±13.65)mm3, significantly larger than that of mice inoculated with breast cancer cells (68.20±9.99 mm3) (P=0.0007).MDA-MB-231 breast cancer stem cells were less sensitive to paclitaxel inhibition than MDA-MB-231 breast cancer cells showing by 50% inhibitory concentration (IC50) [(4.40±0.48) μg/ml vs.(8.20±0.34) μg/ml, P<0.05].However, the expression of transcriptional factors Oct4 was higher in MDA-MB-231 breast cancer stem cells than that in breast cancer cells (P<0.05).The proliferation potential of MDA-MB-231 breast cancer stem cells with Oct4 siRNA interference was significantly lower than that in the negative siRNA and control groups ( P<0.05) from the third day.The invasion ability of MDA-MB-231 breast cancer stem cells with Oct4 siRNA interference was obviously reduced than that in the control and negative siRNA groups shown by number of penetrated cells [(46.52±2.58) vs.(79.67±3.85) and (77.29±2.13), P<0.05 for both].As for resistance to paclitaxel, IC50 of MDA-MB-231 breast cancer stem cells with Oct4siRNA interference was significantly decreased [(4.48±0.22) μg/ml] compared with that in the control [(7.99±0.59) μg/ml] and negative siRNA group [(8.10±0.68) μg/ml] (P<0.05 for both).Conclusions MDA-MB-231 breast cancer cells are successfully obtained by serum-free culture. The proliferation potential, invasion ability and drug resistance of breast cancer stem cells were down-regulated by Oct4 gene knock-down.

Downregulation of PDGF-D Inhibits Proliferation and Invasion in Breast Cancer MDA-MB-231 Cells

PDGF-D Improves Drug Delivery and Efficacy Via Vascular Normalization, but Promotes Lymphatic Metastasis by Activating CXCR4 in Breast Cancer.

Study on the effect of PDGF-D shRNA on proliferation and invasion of breast cancer SK-BR-3 cells

DOWN-REGULATION OF PDGF-D INHIBITS CELL GROWTH AND ANGIOGENESIS THROUGH INACTIVATION OF NOTCH-1 AND NF-κB SIGNALING:

Various Effects of Hepatoma-Derived Growth Factor on Cell Growth, Migration and Invasion of Breast Cancer and Prostate Cancer Cells.

Retraction Note To: FoxM1 Down-Regulation Leads to Inhibition of Proliferation, Migration and Invasion of Breast Cancer Cells Through the Modulation of Extra-Cellular Matrix Degrading Factors

Down‐regulation of Upa and Upar by 3,3′‐diindolylmethane Contributes to the Inhibition of Cell Growth and Migration of Breast Cancer Cells

Downregulation of DPF3 Promotes the Proliferation and Motility of Breast Cancer Cells Through Activating JAK2/STAT3 Signaling.

[Effects of Down-Regulation of CC Chemokine Ligand 5 (CCL5) on Proliferation of Human Breast Cancer Cells in Vitro].

[Effect of Down-Regulation of Oct4 Gene on Biological Characteristics of MDA-MB-231 Breast Cancer Stem Cells].

Effect of Targeted PDGF-B Sirna on the Proliferation of Hep-2 Cells

PD-L2 Expression in Breast Cancer Promotes Tumor Development and Progression

Efef tc of down-regulatoi n of Oct4 gene on biological chaar cteristics ofM DA-MB-231b reast cancer ts em celsl

Silencing of Cluster Determinant 36 Transmitted by Gold Nanoparticles Inhibits the Occurrence and Progression of Breast Cancer by Down-Regulating the Peroxisome Proliferative Activated Receptor Signaling Pathway

Down-regulation of hypoxia-inducible factor-1 suppresses malignant biological behavior of triple-negative breast cancer cells.

Down-Regulation of Hepatoma-Derived Growth Factor Inhibits Anchorage-Independent Growth and Invasion of Non-Small Cell Lung Cancer Cells

Effects of Downregulating Amplified in Breast Cancer 3 Expression by Small Interfering RNA on Transforming Growth Factor-Beta Pathway in Breast Cancer MDA-MB-231 Cells

Platelet-derived growth factor-D promotes colorectal cancer cell migration, invasion and proliferation by regulating Notch1 and matrix metalloproteinase-9

SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast Cancer

Inhibition of FGFR Signaling by PD173074 Improves Antitumor Immunity and Impairs Breast Cancer Metastasis

Effects of Inhibiting Phospholipase C-γ1 on Proliferation and Migration of Breast Cancer Cells